Regeneron Pharma (REGN) PT Jumps More than 50% to $624 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Alethia Young raised the price target on Regeneron Pharma (NASDAQ: REGN) to $624.00 (from $400.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
